Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases

Akkaya C., Kaya B., Kotan Z., Sarandol A., Ersoy C., Kirli S.

JOURNAL OF PSYCHOPHARMACOLOGY, cilt.23, sa.6, ss.723-726, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 6
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1177/0269881108091252
  • Dergi Adı: JOURNAL OF PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.723-726
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Schizophrenia is a chronic and debilitating psychotic mental disorder that affects about 1% of the world's population. Antipsychotic drugs are the mainstay of treatment in schizophrenia. Hyperprolactinemia, which is a common side effect of typical antipsychotics, is also associated with the use of some of the newer atypical agents. Antipsychotics may enhance prolactinoma growth as manifested by an increase in serum prolactin concentration. Prolactin-secreting pituitary adenomas possibly related with antipsychotics have been described in the literature. To our knowledge, this is the first series of cases showing a possible relation between pituitary adenomas and amisulpride treatment in patients with schizophrenia.